Lilly’s Move on Zepbound a ‘Modest Step Forward,’ Sanders Says

Senator Bernie Sanders says he is pleased Eli Lilly has taken a “modest step forward” by reducing the starter price of weight-loss drug Zepbound, but many Americans will still be unable to afford the drugs they need.

• Sanders says in statement Medicare would “likely go bankrupt” with the high prices charged by Eli Lilly and Novo Nordisk
• Sanders, who chairs the Senate Health Committee, says he looks forward to discussing cost of diabetes and weight-loss drugs with CEO of Novo Nordisk at a Senate hearing on Sept. 24
• He also says he looks forward to engaging with Eli Lilly about ...